With no approved pediatric treatments, Lin wonders whether Serena will be able to attend college. As a community representative for the U.S. National Institutes of Health’s long COVID clinical trials ...
The ASX Healthcare sector felt the broader market’s chills for the week ending February 6, 2026, falling as tech and ... Read ...
A University of Calgary-led international research team has identified a genetic factor that may explain why people respond ...
Sanofi’s LEAP2MONO phase 3 study of venglustat to treat type 3 Gaucher disease meets all primary endpoints: Paris Tuesday, February 3, 2026, 13:00 Hrs [IST] Positive results fro ...
In October 2025, KKH opened its first specialised burn centre for children, located next to the hospital’s children's ...
A University of Calgary-led international research team has identified a genetic factor that may explain why people respond ...
Veteran diagnostics leader to accelerate growth and clinical partnerships across pediatric and hospital settings Thomas ...
In 2019, after a routine vaccination, 11-year-old Keithron Thomas felt a sharp pain in his shoulder and down his arm. His ...
This 'fun' kids' outdoor activity causes thousands of injuries a year – here’s how to keep kids safe
Thousands of UK children land in A&E after trampoline fun goes wrong; learn the real risks, key warning signs and smarter ways to keep them safe.
Sanofi’s venglustat met all primary endpoints in a phase 3 study of type 3 Gaucher diseaseIn the LEAP2MONO phase 3 study, venglustat, dosed ...
A University of Calgary-led international research team has identified a genetic factor that may explain why people respond so differently to opioid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results